Navigation Links
Hospira Receives Favorable Court Decision on Eloxatin(R)
Date:6/18/2009

-- Has Tentative FDA Approval and Expects Final Approval Shortly --

LAKE FOREST, Ill., June 18 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. District Court for the District of New Jersey has granted summary judgment of non-infringement in Hospira's favor with regard to Sanofi Aventis' chemotherapy medication Eloxatin(R), and that Hospira has tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of the product. Hospira expects full FDA approval shortly.

Hospira's version of Eloxatin, which goes by the generic name oxaliplatin injection, will be one of the first generic versions available in the United States to come in solution form. U.S. sales of Eloxatin last year were approximately $1.4 billion.

"We are extremely pleased with the court's ruling," said Joshua Gordon, vice president, Specialty Pharmaceuticals, Hospira. "The launch of Hospira's oxaliplatin injection will provide a high-quality, lower-cost alternative to patients, and is another example of Hospira working to meet patient and caregiver needs in the fast-growing oncology market."

Hospira's specialty injectable pharmaceuticals (SIP) offering includes approximately 200 generic injectable drugs in many dosages and formulations. In addition, many of its products are available in popular differentiated formats, several of which are proprietary, such as its ADD-Vantage Drug Delivery System and iSecure(R) prefilled syringes. Therapeutic segments include anesthesia, anti-infectives, analgesics, cardiovascular, oncology, emergency and other areas. Hospira has approximately 25 generic drugs scheduled to launch in various regions around the world in 2009 and 2010.

About Hospira

Hospi
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) Technologies
2. Hospira Names Brian Meadows Supply Chain Chief
3. Hospira Supports Newly Introduced Biogenerics Legislation
4. Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
5. StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists
6. Hospira Hosts Conference Call for Third-Quarter 2008 Earnings
7. Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
8. Hospira Expands Board of Directors
9. Hospiras Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
10. Biogenerics Will Save Billions, Says Hospira CEO
11. Berlin Heart Inc. Receives FDA Orphan Product Development Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Follow us on LinkedIn ... has groomed and nurtured anti-aging products and technologies ... on appearance maintenance is benefitting the market for ... obtained from the bacterium, Clostridium Botulinum, which arrests ... With cosmetic indications for botulinum toxin ranging from ...
(Date:9/22/2014)... (Nasdaq: NEOG ) announced today that net ... year, which ended Aug. 31, was $8,883,000 — a ... the first quarter of last year. Adjusted for a ... share in the current quarter were $0.24, compared to ... increased 15% to $67,599,000, from the previous year,s first ...
(Date:9/22/2014)... Olso, Norway (PRWEB) September 22, 2014 ... convenient new parcel and pallet measuring device ... ScanTape™ eliminates manual data entry, offering greater ease ... time savings that result can significantly enhance productivity—an ... in industries where processing volume equals profits. ...
(Date:9/21/2014)... For the first time, scientists have discovered how to ... strength and stiffness greater than that of today,s strongest ... a research team led by John V. Badding, a ... published in the 21 September 2014 issue of the ... point of view, our discovery is intriguing because the ...
Breaking Biology Technology:Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7ScanTape™ Handheld Dimensioner Increases Processing Volume 2Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4
... Inc.,(Nasdaq: VTIV ) today announced that Eran ... Officer, will make a presentation at the,2008 UBS ... which will,be held February 11-13, 2008. The conference ... management presentations and,extensive Q&A opportunities., inVentiv,s presentation ...
... Services to Unprecedented Number of ... Elderly and Bariatric Patients, MALVERN, Pa., Feb. 4 ... the first facility in the United,States to install the ... (http://www.usa.siemens.com/healthcare ) -- the,MAGNETOM(R) Verio. Combining 3 Tesla ...
... Chantix and Cialis Lead, Many Heavily Advertised Brands ... Manhattan Research, a leader in,syndicated research and marketing ... the top pharmaceutical branded,product websites ranked by offline ... are based on the comprehensive online consumer,research study ...
Cached Biology Technology:inVentiv Health to Present at the 2008 UBS Global Healthcare Services Conference 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 3Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates 2
(Date:9/21/2014)... Stanford researchers has developed a protein therapy that disrupts ... from original tumor sites, travel through the blood stream ... , This process, known as metastasis, can cause cancer ... of patients who succumb to cancer fall prey to ... associate professor of bioengineering who describes a new therapeutic ...
(Date:9/19/2014)... resource unveiled today by researchers from several Harvard ... provides both experienced and aspiring researchers with the ... operate robots made from soft, flexible materials. , ... cutters, and other advances in manufacturing technology, soft ... Using principles drawn from conventional rigid robot design, ...
(Date:9/19/2014)... A University of Oklahoma biology professor will study ... control leg movements with a National Science Foundation ... four-year project. , Ari Berkowitz, professor in the ... Sciences, will focus on the differences between the ... understand what neurotransmitters they use and what connections ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Soft robotics 'toolkit' features everything a robot-maker needs 2
... of a human brain and squeeze it into a special chamber ... chamber filled with cerebral spinal fluid and thread both of them ... makes the neurons and other brain cells behave as if they ... battery of sensors that monitor how the cells respond when exposed ...
... special issue of ZooKeys , initiated by ... Vladimir Blagoderov bring together 18 papers by 81 authors to ... history collections. Centuries of exploration and discovery have documented ... biodiversity are, for the most part, distributed across varied ...
... discovered the structure and operating procedures of a ... alternative to antibiotics. In research published in ... Science USA, scientists from Monash University, The ... how the bacteriophage lysin, PlyC, kills bacteria that ...
Cached Biology News:Vanderbilt-led team to develop 'microbrain' to improve drug testing 2Vanderbilt-led team to develop 'microbrain' to improve drug testing 3Vanderbilt-led team to develop 'microbrain' to improve drug testing 4Vanderbilt-led team to develop 'microbrain' to improve drug testing 5Bringing natural history collections out of the dark 2New recruits in the fight against disease 2
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
... Microplate Luminometer has been designed,for the ... for,all measurements of glow and flash ... the light remain nearly constant,over a ... as for very fast reactions,requiring at ...
... blotting. Get results sooner and save hours of ... Eliminates the need for a membrane transfer step ... are ready-to-use. No reagents to prepare or mix ... required. Guarantees a simple to perform, mistake-free detection ...
... The EZ-Tn5™ Plasmid-Based Deletion Machine is ... vitro transposition system developed by Goryshin and ... generation of nested families of deletions and ... cloned in a transposon-containing plasmid vector. Although ...
Biology Products: